8-K current report · filed Nov 2, 2026

ANAVEX LIFE SCIENCES CORP. (AVXL) 8-K Current Report: November 2, 2026

Item 5.02Item 8.01AVXL overview

Short answer

ANAVEX LIFE SCIENCES CORP. (AVXL) filed an 8-K current report with the SEC on November 2, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 8.01 (Other Events). Three directors resigned effective October 28, 2026: Jiong Ma, Gautam Patel and Adrian Senderowicz.

ANAVEX LIFE SCIENCES CORP. 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Three directors resigned effective October 28, 2026: Jiong Ma, Gautam Patel and Adrian Senderowicz
  • Board departures cited strategic disagreements with management and the remaining directors
  • Ma’s exit removes the Board Chair and an Audit Committee member
  • Patel’s departure creates an additional Audit Committee vacancy
  • Multiple simultaneous resignations signal elevated governance and strategic-execution risk for investors

Item 8.01 · Other Events

  • Board reconstituted all three standing committees effective November 1, 2026
  • Claus van der Velden appointed Audit Committee chair
  • Peter Donhauser appointed Compensation Committee chair
  • Axel Paeger appointed Nominating and Corporate Governance Committee chair

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ANAVEX LIFE SCIENCES CORP. 8-K filings

Get the next AVXL 8-K as it lands

Follow AVXL for push alerts, or ask the research agent what this filing means.